Literature DB >> 12904869

[Cerebrospinal fluid parameters in various stages of HIV infection. Results of cross-sectional and longitudinal analysis].

B Kammer-Suhr1, Ch Heese, A Kulschewski, D Reichelt, St Evers, I-W Husstedt.   

Abstract

In up to 50% of all human immunodeficiency virus (HIV) patients, the nervous system is clinically involved. Primary or secondary manifestations of the nervous system have been found in even 90% by neuropathological investigations. We present a retrospective analysis of cerebrospinal fluid (CSF) and serum data of 238 HIV patients. Data of cross-sectional analysis in 208 patients and longitudinal analysis in 30 patients are given. In addition, the viral load in CSF and serum was determined in 29 patients. The HIV patients without opportunistic infections showed increased levels of immunoglobulins and more oligoclonal bands. In later stages of the infection, beta-2 microglobulin as a marker of HIV-associated encephalopathy was increased. In the longitudinal study with an observation period of 1 year, an increase could be observed in total CSF proteins of patients who did not receive antiretroviral treatment. In patients with new opportunistic infections of the central nervous system, similar changes in CSF parameters were noted as in comparison to patients not infected by HIV but with the same opportunistic infections. Analysis of CSF is mandatory for the diagnosis and control of opportunistic infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904869     DOI: 10.1007/s00115-003-1531-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  22 in total

1.  Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

Authors:  P H Cunningham; D G Smith; C Satchell; D A Cooper; B Brew
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

Review 2.  [HIV-1 associated encephalopathy and myelopathy].

Authors:  C Eggers
Journal:  Nervenarzt       Date:  2000-08       Impact factor: 1.214

Review 3.  Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.

Authors:  P Cinque; A Bestetti; P Morelli; S Presi
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

4.  CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel.

Authors:  D W Marshall; R L Brey; C A Butzin; D R Lucey; S M Abbadessa; R N Boswell
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

Review 5.  Epidemiology and clinical features of HIV-1 associated neuropathies.

Authors:  A Verma
Journal:  J Peripher Nerv Syst       Date:  2001-03       Impact factor: 3.494

6.  Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex.

Authors:  A Krivine; G Force; J Servan; A Cabée; F Rozenberg; L Dighiero; F Marguet; P Lebon
Journal:  J Neurovirol       Date:  1999-10       Impact factor: 2.643

7.  Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.

Authors:  F García; G Niebla; J Romeu; C Vidal; M Plana; M Ortega; L Ruiz; T Gallart; B Clotet; J M Miró; T Pumarola; J M Gatell
Journal:  AIDS       Date:  1999-08-20       Impact factor: 4.177

8.  The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study.

Authors:  J C McArthur; T E Nance-Sproson; D E Griffin; D Hoover; O A Selnes; E N Miller; J B Margolick; B A Cohen; H Farzadegan; A Saah
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

9.  Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

Authors:  Ronald J Ellis; David J Moore; Meredith E Childers; Scott Letendre; J Allen McCutchan; Tanya Wolfson; Stephen A Spector; Karen Hsia; Robert K Heaton; Igor Grant
Journal:  Arch Neurol       Date:  2002-06

10.  Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

Authors:  D D Ho; T R Rota; R T Schooley; J C Kaplan; J D Allan; J E Groopman; L Resnick; D Felsenstein; C A Andrews; M S Hirsch
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

View more
  2 in total

Review 1.  [Epidemiology and therapy of pain and depression during HIV and AIDS].

Authors:  I W Husstedt; D Reichelt; F Kästner; S Evers; K Hahn
Journal:  Schmerz       Date:  2009-12       Impact factor: 1.107

2.  Genetic Determinants of Antibody Levels in Cerebrospinal Fluid in Multiple Sclerosis: Possible Links to Endogenous Retroviruses.

Authors:  Alexander Emmer; Christine Brütting; Malte Kornhuber; Martin S Staege
Journal:  Int J Mol Sci       Date:  2018-03-09       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.